Good Lifestyle

Currently, you can protect against COVID by providing two doses of the Pfizer or Modern vaccine, or getting a Johnson & Johnson vaccine dose. Quite vaccinated offers you the highest level of protection against the new coronavirus, but this immunity may not last over time, so the three vaccine manufacturers are already working onshots. Experts are not quite sure of the decline in these follow-up vaccinations, however, and there are many debates on what theFuture of Booster Shots Looks like. But the CEO of Moderna recently opened on what society focuses on its booster and says there are four conditions that will determine the timing of your next Covid vaccine.

RELATED:How long is the Moderna vaccine really protects you, the study says.

During the Health Forbes Health Summit on June 8, CEO of ModernaStéphane Bantelsays that theCurrent vaccines produced By Moderna, Pfizer and Johnson & Johnson will not be enough to provide immunity against Covid forever, especially withVirus variants continues to propagate worldwide. And this means that boosters will probably be necessary in the near future, but at your disposal for each individual will depend on four factors: when your immunity decreases, the emergence of new variants, how old are you and all the underlying conditions that You may have.

"First, Wanses of immunity with time Meaning of the antibody roller that you have in your body of the vaccine - all natural infections fall in time," said Bantel. "Two is that you do not know which virus you will be infected by the road ... or even a new one that we do not know yet. And then it depends on your age and your medical condition."

Bantel explained during the Goldman Sachs 42th Healthcare Annual Conference on June 8thImmunity is likely to decrease earlier For those who are older and have more underlying conditions because they have received their initial vaccinations first in December and January, some are therefore "arriving in September in their 10-month clock", A-T -he declares.

"I think for the next fall, because a community should be two months too early than two months too late. And there is no way to know exactly when people should be boosted," said Bantel. "So, since we all evolve very uncertain data with a new virus, I think to be careful and stimulate early will be wise for this pandemic phase of the stimulation phase of 2022 or the end of 2021."

RELATED:For more information up to date, sign up for our daily newsletter.

According to Bondel, Moderna is currentlyBoost This targets both antibodies and new variants. The shot will restart pre-existing antibodies developed by initial vaccinations or earlier infections, as well as "providing new antibodies into your body that will specifically connect with these new mutations" found in emerging variants.

In addition to this, Moderna also develops an influenza vaccine, said Bondel. The company is currently working on a booster for seasonal flu which operates with an efficiency of 90 to 95%, much higher than the habitual influenza vaccineEfficiency rate of 40 to 60%, according to the disease control centers and prevention (CDC).

Moderna also ultimately hopes to produce a vaccine that providesCap protection and flu With one shot. "Our vision is to combine essentially what we believe will be shot on high-efficiency fluid influenza with COVID booster variants, all combined in one dose," said Bantel at the Goldman Sachs conference.

RELATED:If you have Pfizer, it's when you need a booster, Director of Management.